Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Sensei Biotherapeutics, Inc. (SNSE) had Pre-Tax Income of $-4.94M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.94M |
|
-- |
|
-- |
|
$5.21M |
|
$-5.21M |
|
$0.27M |
|
|
Pre-Tax Income |
$-4.94M |
$-4.90M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.90M |
|
$-5.21M |
|
$-5.17M |
|
1.26M |
|
1.26M |
|
$-3.91 |
|
$-3.91 |
|
| Balance Sheet Financials | |
$29.57M |
|
$0.14M |
|
$2.21M |
|
$31.78M |
|
$3.87M |
|
$0.00M |
|
$0.60M |
|
$4.47M |
|
$27.31M |
|
$27.31M |
|
$27.31M |
|
1.26M |
|
| Cash Flow Statement Financials | |
$-13.00M |
|
$15.95M |
|
$-0.38M |
|
$9.99M |
|
$12.56M |
|
$2.56M |
|
$0.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.64 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.07% |
|
-18.07% |
|
-15.53% |
|
-18.07% |
|
$21.66 |
|
$-10.13 |
|
$-10.31 |
|